Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hester Biosciences's share price for the quarter that ended in Mar. 2026 was ₹1262.65. Hester Biosciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 9 Mil. Therefore, Hester Biosciences's market cap for the quarter that ended in Mar. 2026 was ₹10,741 Mil.
Hester Biosciences's quarterly market cap
declined
from Sep. 2025 (₹16,101 Mil) to Dec. 2025 (₹13,543 Mil) and
declined
from Dec. 2025 (₹13,543 Mil) to Mar. 2026 (₹10,741 Mil).
Hester Biosciences's annual market cap
declined
from Mar. 2024 (₹11,818 Mil) to Mar. 2025 (₹10,667 Mil) but then
increased
from Mar. 2025 (₹10,667 Mil) to Mar. 2026 (₹10,741 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hester Biosciences's Enterprise Value for Today is ₹19,938 Mil.
Hester Biosciences (BOM:524669) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hester Biosciences Market Cap Related Terms
Hester Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Hester Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hester Biosciences Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Hester Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hester Biosciences's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hester Biosciences (BOM:524669) has a Market Cap of ₹17,944 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hester Biosciences and its competitors. According to the industry distribution chart, Hester Biosciences ranks #532 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 52%.
Is Hester Biosciences' Market Cap too high?
Hester Biosciences' current Market Cap is ₹17,944 Mil. Based on the distribution chart, Hester Biosciences ranks #532 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hester Biosciences has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hester Biosciences' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hester Biosciences ranks #532 out of 1024 companies for Market Cap. This places Hester Biosciences in the lower half of its industry. The industry median Market Cap is 213.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.52, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hester Biosciences and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hester Biosciences's current Market Cap is ₹17,944 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hester Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Hester Biosciences (BOM:524669) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,889.64, compared to a current price of ₹2,109.40 — trading 11.6% above its estimated fair value. The current Market Cap is ₹17,944 Mil. Hester Biosciences' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hester Biosciences (BOM:524669), the current Market Cap is ₹17,944 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hester Biosciences (BOM:524669) Overvalued in 2026?
Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued.
The current stock price of ₹2,109.40 is trading 11.6% above its estimated GF Value™ of ₹1,889.64.
GuruFocus considers Hester Biosciences to be Modestly Overvalued.
Key valuation signals for BOM:524669:
Market Cap: ₹17,944 Mil
GF Value™: ₹1,889.64 vs. price of ₹2,109.40 (11.6% above fair value)
No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
79GF Score
Get the complete analysis for BOM:524669
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524669 has been successfully added to your 
